Dynamic quotes: Off
|
ETFs with GSK as a Top 10 Holding*Sponsored by:
| Weighting | ETF Name (Symbol) | 100-Day Price Change (%) |
|---|---|---|
| 5.76% | Merrill Lynch Pharmaceutical HOLDRS (PPH) | +8.03 (20.41%) |
| 3.65% | BLDRS Europe 100 ADR Index Fund (ADRU) | +1.04 (4.97%) |
|
||
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
• “CEO’s review” on pages 3 to 4 (excluding the information in the second paragraph under the heading “Outlook” on page 4); • “How we performed” on pages 6 to 7; • “What we do” on page 8; • “Where we do it” on page 9; • “How we create value” on pages 10 to 11; -------------------------------------------------------------------------------- Table of Contents • “Our market” on pages 12 to 15 (excluding the information in the second paragraph under the heading “Outlook” on page 15); • “How we deliver” on pages 16 to 17; • “Deliver more products of value” on pages 30 to 31; • “Investment in R&D” on page 32; • “Pharmaceuticals R&D” on pages 33 to 36; • “Vaccines R&D” on pages 37 to 38; • “Consumer Healthcare R&D” on page 39; • “Late stage pi ... More ...
Consensus Recommendation |
|
Analyst Info |
|
| Annual EPS Est: | $3.58 |
| Quarterly EPS Est: | 0.88 |
| PEG Ratio: | 2.19 |
|
Mean Recommendation: View Summary / View All |
3 |
Data is provided by Zacks Investment Research